Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD
Clinical trial NCT01959516 · COMPLETED
Trial details
- NCT number
- NCT01959516
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-10-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.